May 21 2010 Speaker bio added:
Mark A. Waring, Consultant, Corporate Strategy
May 20 2010
Speaker bio added:
Hoyoung Huh, M.D., Ph.D., Chairman, BiPar Sciences
May 19 2010
Agenda updated
Speaker bio added:
Jeff Jonker, J.D., Chief Business Officer, Satori Pharmaceuticals
May 18 2010
Agenda updated
May 14 2010
Speaker bios added:
Mark Edwards, Managing Director, Deloitte Recap LLC & Founder, Recombinant Capital
John Mendlein Ph.D., Chairman, Fate Therapeutics
Stephen A. Williams, M.D., Ph.D., Chief Medical Officer , SomaLogic
May 13 2010
Speaker bios added:
Peter Payne, VP, Corporate Development, Quintiles Transnational Corp
James Sabry, VP Genentech Partnering, Genentech
Augustine Yee, Senior Director, Global Corporate Business Development, AstraZeneca Pharmaceuticals
May 12 2010
Speaker bios added:
Daniel J. Curran, M.D., VP, Corporate Development, Millennium/Takeda
Rinko Ghosh, SVP and CBO, Nektar Therapeutics
Jim McLoughlin, Executive Director, R&D Business Development, Pfizer
Lisa Natanson, Deloitte Recap LLC, Deloitte
May 11 2010
Speaker bios added:
Katrine Bosley, CEO, Avila Therapeutics
Allen Downs, Senior Executive Director, Licensing & Business Development, Purdue Pharma
David C. Hastings, EVP, Chief Financial Officer, Incyte Corporation
Paul J. Hastings, President & CEO, OncoMed Pharmaceuticals
Michael G. McCully, Deloitte Recap LLC, Deloitte
George Milstein, Head of Healthcare M&A, Wedbush Pacific Growth Life Sciences
Bernard Munos, Advisor, Corporate Strategy, Eli Lilly
Polly A. Murphy, VP, R&D Business Development, Pfizer
Kelly Powell, Senior Director, Amylin Pharmaceuticals, Inc.
Raul R. Rodriguez, EVP and Chief Operating Officer, Rigel
Gino Santini, SVP, Corporate Strategy and Business Development, Eli Lilly
R. Christopher Seaton, SVP, Global Transactions, Bayer Healthcare Pharmaceuticals
Robert Silverman, Global Licensing Director, Roche
Barbara Yanni, VP & Chief Licensing Officer, Merck & Co
May 10 2010
Agenda updated
Speakers added:
Daniel J. Curran, M.D., VP, Corporate Development, Millennium: The Takeda Oncology Company
Rinko Ghosh, SVP and CBO, Nektar Therapeutics
Paul J. Hastings, President & CEO, OncoMed Pharmaceuticals
Hoyoung Huh, MD, PhD, Former President and CEO, BiPar Sciences
Augustine Yee, Senior Director, Global Corporate Business Development, AstraZeneca Pharmaceuticals
May 7 2010
Speaker bios added:
Jeffrey P. Brennan, SVP & CBO, Business & Commercial Development, Targacept, Inc.
Cláudia Hirawat, SVP Corporate Development, PTC Therapeutics
May 6 2010
Speaker bio added:
Graham R. Brazier, VP & Head of Transactions, Strategic Transactions Group, Bristol Myers Squibb
April 29 2010
Breakthrough Ballot available
April 28 2010
Speaker bio added:
Brent Bankosky, Director, Global Licensing & Business Development, Takeda Pharmaceuticals International, Inc.
April 22 2010
Speakers added:
Brent Bankosky, Director, Global Licensing & Business Development, Takeda Pharmaceuticals International, Inc.
Robert I. Blum , President and CEO , Cytokinetics, Inc.
Jeffrey P. Brennan, VP, Business & Commercial Development, Targacept, Inc.
Kelly Powell, Senior Director, Amylin Pharmaceuticals, Inc.
James Sabry, VP Business Development, Genentech, Inc.
Speaker bio added:
Arlene M. Morris, President and CEO, Affymax, Inc.
April 21 2010
Agenda updated
Speaker bios added:
Eric Dobmeier, Chief Business Officer, Seattle Genetics
Oleg Nodelman, Portfolio Manager, Biotechnology Value Fund
Ed Saltzman, President, Defined Health
April 20 2010
Agenda updated
Speaker added:
Cláudia Hirawat, SVP Corporate Development, PTC Therapeutics
April 19 2010
Agenda available
April 15 2010
Speaker bio added:
Michael Lytton, EVP, Business and Corporate Development, Biogen Idec
April 12 2010
Speaker bios added:
Randall B. Sunberg, Partner, Morgan, Lewis & Bockius
Klaus Wilgenbus, Corporate Senior Vice President, Boehringer Ingelheim
April 9 2010
Speaker bio added:
Timothy F. Herpin Ph.D., Director, Search and Evaluation, Bristol Myers Squibb
April 8 2010
Speaker bio added:
Frances K. Heller, EVP, Business Development, Exelixis
April 7 2010
Speaker bios added:
Jeremy Grunstein, Director, Strategy & Corporate Development, Amgen
Kingsley Taft, Partner, Goodwin Procter LLP
April 2 2010
Speakers added:
George Milstein, Head of Healthcare M&A, Wedbush Pacific Growth Life Sciences
Oleg Nodelman, Portfolio Manager, Biotechnology Value Fund
Stephen A. Williams, M.D., Ph.D., Chief Medical Officer , SomaLogic
March 31 2010
Speaker added:
David C. Hastings, EVP, Chief Financial Officer, Incyte Corporation
March 17 2010
Speakers' list added:
Nov 5 2009
Allicense 2010 Registration
Special rate available for The Fairmont Hotel ( Conference location ) |
|